Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related event
Related Products
Reset
TitlePublishedTypeProducts
eTOXsys - Highly Relevant Proprietary Data and Predictive Models for Drug DevelopmentOctober 2016pdf fileETOX
eTOXsys – Highly relevant proprietary data and predictive models for drug developmentNovember 2016ETOX
eTOXsys – Highly relevant proprietary data and predictive models for drug development - A DemonstrationNovember 2016
eTOXsys - Highly Relevant Proprietary Data and Predictive Models for Drug DiscoveryMarch 2017pdf fileETOX
eTRANSAFE, a New Player in Translational Safety AssessmentMarch 2018pdf file
Evaluation Of A Statistics-based Ames Mutagenicity QSAR Model And Interpretation Of The Results ObtainedDecember 2015Sarah Nexus
Evaluation Of The Statistics-Based Ames Mutagenicity Model Sarah Nexus And Interpretation Of The Results ObtainedApril 2016Sarah Nexus
Examining the myths and realities of aromatic amine mutagenicityJuly 2015pdf fileDerek NexusMeteor Nexus
Examining the role of in silico assessment in skin sensitisation integrated testing strategiesApril 2015Derek Nexus
Examining the role of in silico assessment in skin sensitisation integrated testing strategies.pdfMarch 2015pdf fileDerek Nexus
Examples of expert systems for toxicity and metabolism predictionJune 2015pdf fileDerek NexusMeteor Nexus
Excipients 2014.1.0 Release Notes.pdfMay 2014pdf fileExcipients
Excipients data sharing initiative a step towards 3-R principle implementation.pdfOctober 2013pdf fileExcipientsVitic Nexus
Excipients Database 2018.1.0 Release NotesJune 2018pdf fileVitic NexusExcipients
Expert Review of EC3 PredictionsApril 2017Derek Nexus
Expert Review of In Silico Predictions for Skin Sensitization PotencySeptember 2017pdf fileDerek Nexus
Expert review of the mutagenicity of carbamates - using (Q)SAR predictions for ICH M7 classificationMarch 2017pdf fileDerek NexusSarah NexusVitic Nexus
Expert Systems - The Use of Expert Systems in Drug Design-Toxicity and MetabolismJanuary 2012Derek NexusMeteor Nexus
Explaining and demonstrating successful use of purging and depletion strategies to control mutagenic impuritiesSeptember 2014pdf fileMirabilis
Explaining and demonstrating successful use of purging and depletion strategies to control mutagenic impurities.pdfSeptember 2014pdf fileMirabilis
Explora, A New Language to Define Powerful Structural Queries.pdfJune 2011pdf fileDerek Nexus
Extrapolation of in vitro mutagenicity alerts to the in vivo endpoint in Derek NexusAugust 2017pdf fileDerek Nexus
FDA/CDER Current Practices for (Q)SAR Analysis under ICH M7.pdfApril 2014pdf file
Feature combination networks for the interpretation of statistical machine learning models: application to Ames mutagenicityMarch 2014
Feature combinations networks with statistical QSAR models.pdfSeptember 2014pdf file

© 2018 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.